Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greatest decrease » treatment decreased (Expand Search), greater increase (Expand Search)
level increased » levels increased (Expand Search), levels decreased (Expand Search), gene increased (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greatest decrease » treatment decreased (Expand Search), greater increase (Expand Search)
level increased » levels increased (Expand Search), levels decreased (Expand Search), gene increased (Expand Search)
-
20661
Table 1_Efficacy and safety of telitacicept in the treatment of IgA nephropathy: a single-center, real-world study.docx
Published 2025“…</p>Results<p>Mean serum creatinine and eGFR levels remained stable in all three groups. After 12 weeks and 24 weeks of treatment, patients in all three groups showed a significant decrease in 24 h proteinuria from baseline (P < 0.05). …”
-
20662
Table 1_Apigenin protects ischemic stroke by regulating intestinal microbiota homeostasis, regulates brain metabolic profile.xlsx
Published 2025“…</p>Results<p>The intervention with apigenin resulted in significant alterations in the intestinal flora, characterized by an increase in the abundance of probiotic species and a decrease in harmful flora, alongside notable changes in brain metabolite profiles. …”
-
20663
Data Sheet 1_Impact of meteorological factors on influenza incidence in Wuxi from 2014 to 2019: a time series and comprehensive analysis.docx
Published 2025“…Seven influenza peaks, observed every winter to spring and only one summer (2015), were noted. For a unit increase in weekly average pressure, temperature, wind speed, relative humidity, precipitation, and sunshine duration, the risk of influenza increased by 7.37%, decreased by 8.39%, decreased by 33.83%, increased by 6.44% when relative humidity was >68.86%, increased by 19.91% when precipitation was ≤ 6.13 mm, and decreased by 11.41% when sunshine duration was ≤ 6.30 h, respectively. …”
-
20664
Computed tomography-guided radiofrequency ablation of nasal carcinomas in dogs.
Published 2024“…Post-RFA CT examinations demonstrated a significant decrease in Hounsfield units and tumor volume. …”
-
20665
No effect of PTL on pure primary mouse motor neuron cultures.
Published 2025“…<p>MEA measurements showed that there were no significant differences between the individual wells of plated motor neurons before treatment After 24 and 48 hours, only the LPS+PTL 5 µ M group showed a significant decrease in resistance (A) and in firing rate (B), while all other conditions showed no significant differences between each other. …”
-
20666
Table 6_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.xlsx
Published 2025“…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA<sup>+</sup> MCs), with a concomitant decrease in proliferative MCs (TNF<sup>+</sup> MCs) and resting MCs. …”
-
20667
Image 1_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.jpeg
Published 2025“…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA<sup>+</sup> MCs), with a concomitant decrease in proliferative MCs (TNF<sup>+</sup> MCs) and resting MCs. …”
-
20668
Table 1_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.xlsx
Published 2025“…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA<sup>+</sup> MCs), with a concomitant decrease in proliferative MCs (TNF<sup>+</sup> MCs) and resting MCs. …”
-
20669
Image 4_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.jpeg
Published 2025“…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA<sup>+</sup> MCs), with a concomitant decrease in proliferative MCs (TNF<sup>+</sup> MCs) and resting MCs. …”
-
20670
Table 7_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.xlsx
Published 2025“…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA<sup>+</sup> MCs), with a concomitant decrease in proliferative MCs (TNF<sup>+</sup> MCs) and resting MCs. …”
-
20671
Table 4_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.xlsx
Published 2025“…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA<sup>+</sup> MCs), with a concomitant decrease in proliferative MCs (TNF<sup>+</sup> MCs) and resting MCs. …”
-
20672
Table 5_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.xlsx
Published 2025“…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA<sup>+</sup> MCs), with a concomitant decrease in proliferative MCs (TNF<sup>+</sup> MCs) and resting MCs. …”
-
20673
Table 2_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.xlsx
Published 2025“…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA<sup>+</sup> MCs), with a concomitant decrease in proliferative MCs (TNF<sup>+</sup> MCs) and resting MCs. …”
-
20674
Image 3_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.jpeg
Published 2025“…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA<sup>+</sup> MCs), with a concomitant decrease in proliferative MCs (TNF<sup>+</sup> MCs) and resting MCs. …”
-
20675
Image 5_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.jpeg
Published 2025“…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA<sup>+</sup> MCs), with a concomitant decrease in proliferative MCs (TNF<sup>+</sup> MCs) and resting MCs. …”
-
20676
Table 3_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.xlsx
Published 2025“…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA<sup>+</sup> MCs), with a concomitant decrease in proliferative MCs (TNF<sup>+</sup> MCs) and resting MCs. …”
-
20677
Table 9_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.xlsx
Published 2025“…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA<sup>+</sup> MCs), with a concomitant decrease in proliferative MCs (TNF<sup>+</sup> MCs) and resting MCs. …”
-
20678
Table 8_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.xlsx
Published 2025“…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA<sup>+</sup> MCs), with a concomitant decrease in proliferative MCs (TNF<sup>+</sup> MCs) and resting MCs. …”
-
20679
Image 2_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.jpeg
Published 2025“…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA<sup>+</sup> MCs), with a concomitant decrease in proliferative MCs (TNF<sup>+</sup> MCs) and resting MCs. …”
-
20680
Supplementary Figure 4 from A Pilot Study of the CD38 Antagonist Daratumumab in Patients with Metastatic Renal Cell Carcinoma or Muscle-Invasive Bladder Cancer
Published 2024“…<p>Flow cytometry of immune cells from serially collected blood samples with evidence of significant decrease in circulating NK cells in: A) Metastatic renal cell carcinoma cohort. …”